-
1 Comment
Humana AB (publ) is currently in a long term downtrend where the price is trading 2.1% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Humana AB (publ)'s total revenue rose by 2.3% to $2B since the same quarter in the previous year.
Its net income has increased by 177.8% to $50M since the same quarter in the previous year.
Finally, its free cash flow grew by 8.6% to $239M since the same quarter in the previous year.
Based on the above factors, Humana AB (publ) gets an overall score of 4/5.
ISIN | SE0008040653 |
---|---|
Sector | Healthcare |
Industry | Medical Care Facilities |
Exchange | F |
CurrencyCode | EUR |
Target Price | None |
---|---|
Dividend Yield | None |
Beta | 0.37 |
Market Cap | 192M |
Humana AB (publ) provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark. It operates through three segments: Sweden, Finland, and Norway. The company provides care and treatment for psychosocial disorders, mental illness, and functional impairment; residential care homes; family care services; short-term, short term housing, day crare, and special service housing; outpatient care; assisted living homes; and specially adapted housing for individuals with functional impairments. It also offers care services and assistance to individuals with permanent functional impairments. In addition, the company provides elderly care home services. Further, it offers individual and family care for children, young people and families, and elderly care services, as well as housing services for elderly, individuals with disabilities, mental illness, and/or substance abuse problems; and special service housing for people with functional impairments. The company was founded in 2001 and is headquartered in Stockholm, Sweden.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 47H.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025